A report and follow up of a patient with disseminated superficial actinic porokeratosis (DSAP) undergoing novel systemic treatment with palifermin (a keratinocyte growth factor) during chemotherapy
Version 2 2024-06-13, 11:30Version 2 2024-06-13, 11:30
Version 1 2021-10-20, 11:04Version 1 2021-10-20, 11:04
journal contribution
posted on 2024-06-13, 11:30authored byM Howard, A Hall
A report and follow up of a patient with disseminated superficial actinic porokeratosis (DSAP) undergoing novel systemic treatment with palifermin (a keratinocyte growth factor) during chemotherapy